Alexion Pharmaceuticals, Inc. (ALXN) Q1 2020 Results Earnings Conference Call May 6, 2020 8:00 AM ET
Company Participants
Chris Stevo - Head of Investor Relations
Ludwig Hantson - Chief Executive Officer
Aradhana Sarin - Chief Financial Officer
John Orloff - Global Head of R&D
Brian Goff - Chief Commercial and Global Operations Officer
Conference Call Participants
Cory Kasimov - JPMorgan
Geoffrey Porges - SVB Leerink
Chris Raymond - Piper Sandler
Paul Matteis - Stifel
Geoff Meacham - Bank of America
Mohit Bansal - Citigroup
Phil Nadeau - Cowen & Company
Robyn Karnauskas - SunTrust
Matthew Harrison - Morgan Stanley
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Alexion Pharmaceuticals, Incorporated First Quarter 2020 Conference Call. At this time, all participant lines are in a listen-only mode. After the speaker’s presentation, there will be a question-and-answer session. [Operator Instructions]
At this time, I would like to hand the conference over to Mr. Chris Stevo, Head of Investor Relations.
Chris Stevo
Thank you, operator. Good morning. Thank you for joining us on today’s call to discuss Alexion’s performance for the first quarter of 2020. Today’s call will be led by Ludwig Hantson, our CEO. Ludwig will be joined by Aradhana Sarin, our Chief Financial Officer; John Orloff, our Global Head of R&D; and Brian Goff, our Chief Commercial and Global Operations Officer.
I will note that we are practicing physical distancing, and each will be doing the call from home. You can access the webcast slides that will be presented on this call by going to the Event Section of our Investor Relations page on our website.
Before we begin, I would like to point out that we will be making forward-looking statements, and these statements involve certain risks and uncertainties that could cause our actual results to differ
- Read more current ALXN analysis and news
- View all earnings call transcripts